- Home
- RPRX vs DOV Comparison
RPRX vs DOV Comparison
Compare RPRX & DOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | DOV |
|---|---|---|
| Founded | 1996 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 28.8B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RPRX | DOV |
|---|---|---|
| Price | $63.63 | $190.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | $51.40 | ★ $240.17 |
| AVG Volume (30 Days) | ★ 2.6M | 916.9K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | ★ 1.90% | 0.94% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.71 | ★ 4.06 |
| Revenue | $2,378,193,000.00 | ★ $6,992,118,000.00 |
| Revenue This Year | $38.63 | $6.93 |
| Revenue Next Year | $4.73 | $4.47 |
| P/E Ratio | $88.89 | ★ $46.53 |
| Revenue Growth | ★ 5.06 | 2.51 |
| 52 Week Low | $34.63 | $158.97 |
| 52 Week High | $63.29 | $237.54 |
Technical Indicators
Market Signals| Indicator | RPRX | DOV |
|---|---|---|
| Relative Strength Index (RSI) | 68.15 | 31.26 |
| Support Level | $38.07 | N/A |
| Resistance Level | N/A | $202.30 |
| Average True Range (ATR) | 1.26 | 3.80 |
| MACD | 0.19 | -1.33 |
| Stochastic Oscillator | 97.35 | 12.64 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About DOV Dover Corporation
Founded in 1955 by George Ohrstrom, Dover has become an industrial behemoth through the acquisition of dozens of esteemed brands. The company is organized into five segments through which it designs and manufactures highly engineered components, such as vehicle repair, factory automation, welding, aerospace, fuel dispensing, printing, liquid handling, refrigeration, and can-making equipment. It has operations around the globe but generates over half of its revenue in the United States.